Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Landos Biopharma, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 33 | 35 | +2 |
| Shares | 22.7M | 22.7M | −39.0K (−0.2%) |
| Value | $261.4M | $331.1M | +$69.6M (+26.6%) |
New holders (5)
Institutions that held Landos Biopharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 18,831 | $275.0K | 0.00% |
| Jacobs Levy Equity Management, Inc | 18,174 | $265.0K | 0.00% |
| Renaissance Technologies LLC | 10,900 | $159.0K | 0.00% |
| Allworth Financial LP | 5,286 | $77.0K | 0.00% |
| Cahill Financial Advisors Inc | 100 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Landos Biopharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Tudor Investment Corp Et Al | 17,793 | $206.0K |
| Nuveen Asset Management, LLC | 10,219 | $118.0K |
| Wells Fargo & Company | 9,526 | $110.0K |